Precision Medicine News and Research

RSS

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Detecting mental disorders with data from wearables

Depression and anxiety are among the most common mental health disorders in the United States, but more than half of people struggling with the conditions are not diagnosed and treated.

23 May 2023

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.

22 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

A new study examining the criteria proposed by the European Society of Cardiology (ESC) to prescribe long-term treatment with more than one blood thinner after percutaneous coronary intervention was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Australian nanomedicine researchers have come up with a new approach to solving a decades-old clinical problem: getting treatment drugs to act selectively on cancer cells in the body.

18 May 2023

Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicine combination therapeutics

Closed Loop Medicine Ltd, a leading TechBio company, today announced that they have entered a global co-development partnership.

From Closed Loop Medicine 17 May 2023

Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that it had won an award from the U.S. Defense Innovation Unit for ‘Exhaled Breath Diagnostics’.

From Owlstone Medical Ltd 17 May 2023

NIH launches landmark initiative to advance nutrition research

The National Institutes of Health is now enrolling participants in a landmark initiative to advance nutrition research.

16 May 2023

Advancing Precision Medicine in Argentina, Brazil and Chile – BGI Update

BGI Genomics recently participated in a mission business to South America in April 2023.

From BGI Genomics 16 May 2023

Researchers develop a computational approach to predict diabetic kidney disease

Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease, a frequent and dangerous complication of diabetes.

15 May 2023

COVID-19 infection may promote aortic aneurysms and new treatment may slow its growth

The intravenous delivery of immune-modulating cells may someday slow the expansion of bulges in the aorta, known as abdominal aortic aneurysms.

10 May 2023

Researchers create new "pangenome" that provides better view of human genome

When it was launched in April 2003, the Human Genome Project helped revolutionize biomedical research by providing scientists a reference map that allowed them to analyze DNA sequences for genetic clues to the origins of a host of diseases.

10 May 2023

MGI empowers the completion of nearly 60,000 samples for the million microbiome of humans project

Through the Million Microbiome of Humans Project, MGI Tech is building a comprehensive microbiome database to support global health and research initiatives.

From MGI 10 May 2023

Study reports cost-effectiveness of population genetic testing

An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

9 May 2023

Differences in genetics, lifestyle factors likely have unique effects on CVD risk in Asian Americans

Asian Americans have significant differences in genetics, socioeconomic factors, culture, diet, lifestyle, health interventions and acculturation levels based on the Asian region of their ancestry that likely have unique effects on their risk for heart disease and Type 2 diabetes, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 May 2023

Precision Medicine News and Research

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Detecting mental disorders with data from wearables

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicine combination therapeutics

Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection

NIH launches landmark initiative to advance nutrition research

Advancing Precision Medicine in Argentina, Brazil and Chile – BGI Update

Researchers develop a computational approach to predict diabetic kidney disease

COVID-19 infection may promote aortic aneurysms and new treatment may slow its growth

Researchers create new "pangenome" that provides better view of human genome

MGI empowers the completion of nearly 60,000 samples for the million microbiome of humans project

Study reports cost-effectiveness of population genetic testing

Differences in genetics, lifestyle factors likely have unique effects on CVD risk in Asian Americans

NIH researchers identify new genetic risk factors for two types of non-Alzheimer's dementia

The Evolution of Molecular Biology

The African Personalized Medicine Agenda

How the COVID pandemic has improved genomics

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News